Physiological and pathological regulation of the autonomic control of urinary bladder contractility

Pharmacology and Therapeutics

Volumn 117, Issue 3, 2008, Pages 297-312

  Michel, Martin C ^a   Barendrecht, Maurits M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adrenergic receptor; Ageing; Bladder contraction; Bladder outlet obstruction; Gender; Muscarinic receptor

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL; CARBACHOL; DARIFENACIN; DOXAZOSIN; ISOPRENALINE; L 755507; METHOCTRAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; PHOSPHOLIPASE C; PROPIVERINE; UNCLASSIFIED DRUG;

AGING; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLADDER CONTRACTION; BLADDER DYSFUNCTION; BLADDER NECK STENOSIS; DETRUSOR DYSSYNERGIA; DIABETES MELLITUS; DIURESIS; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; HUMAN; HYPERTENSION; NONHUMAN; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; URINE INCONTINENCE;

AGING; ANIMALS; AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; SEX FACTORS; URETHRAL OBSTRUCTION; URINARY BLADDER; URINARY INCONTINENCE;

EID: 39549119348     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.12.001     Document Type: Review

References (188)

1. Abrams P. Nocturia: The major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO). Eur Urol Suppl 3 (2005) 8-16
2. Abrams P., Andersson K.E., Buccafusco J.J., Chapple C., De Groat W.C., Fryer A.D., et al. Muscarinic receptors: Their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148 (2006) 565-578
3. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., et al. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21 (2002) 167-178
4. Afiatpour P., Latifpour J., Takahashi W., Yono M., Foster Jr. H.E., Ikeda K., et al. Developmental changes in the functional, biochemical and molecular properties of rat bladder endothelin receptors. Naunyn-Schmiedeberg's Arch Pharmacol 367 (2003) 462-472
5. Agartan C.A., Whitbeck C., Chichester P., Kogan B.A., and Levin R.M. Effect of age on rabbit bladder function and structure following partial outlet obstruction. J Urol 173 (2005) 1400-1405
6. An J.Y., Yun H.S., Lee Y.P., Yang S.J., Shim J.O., Jeong J.H., et al. The intracellular pathway of the acetylcholine-induced contraction in cat detrusor muscle cells. Br J Pharmacol 137 (2002) 1001-1010
7. Andersen J.T. Detrusor hyperreflexia in benign infravesical obstruction. A cystometric study. J Urol 115 (1976) 532-534
8. Andersson K.E. Tachykinins: Role in detrusor overactivity?. Eur Urol 49 (2006) 423-425
9. Andersson K.E., and Arner A. Urinary bladder contraction and relaxation: Physiology and pathophysiology. Physiol Rev 84 (2004) 935-986
10. Andersson K.E., and Wein A.J. Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence. Pharmacol Rev 56 (2004) 581-631
11. Apostolidis A., Dasgupta P., and Fowler C.J. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49 (2006) 644-650
12. Austin J.C., Chacko S.K., Disanto M., Canning D.A., and Zderic S.A. A male murine model of partial bladder outlet obstruction reveals changes in detrusor morphology, contractility and myosin isoform expression. J Urol 172 (2004) 1524-1528
13. Avelino A., and Cruz F. TRPV1 (vanilloid receptor) in the urinary tract: Expression, function and clinical applications. Naunyn-Schmiedeberg's. Arch Pharmacol 373 (2006) 287-299
14. 1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn. doi:10.1002/nau.20481
15. Barendrecht M.M., Chichester P., Michel M.C., and Levin R.M. Effect of short-term outlet obstruction on rat bladder nerve density and contractility. Auton Autacoid Pharmacol 27 (2007) 47-54
16. Barendrecht M.M., Frazier E.P., Vrydag W., Alewijnse A.E., Peters S.L.M., and Michel M.C. Effects of outlet obstruction on rat bladder contraction and relaxation by adrenoceptor agonists. Eur Urol Suppl 6 (2007) 35
17. Bellucci F., Cucchi P., Santicioli P., Lazzeri M., Turini D., and Meini S. Characterization of kinin receptors in human cultured detrusor smooth muscle cells. Br J Pharmacol 150 (2007) 192-199
18. Birder L.A., and De Groat W.C. Mechanisms of disease: Involvement of the urothelium in bladder dysfunction. Nature Clin Pract Urol 4 (2007) 46-54
19. Borchert V.E., Czyborra P., Fetscher C., Goepel M., and Michel M.C. Extracts from Rhois aromatica and Solidaginis vigaurea inhibit rat and human bladder contraction. Naunyn-Schmiedeberg's Arch Pharmacol 369 (2004) 281-286
20. Brading A.F. A myogenic basis for the overactive bladder. Urology 50 Suppl. 6A (1997) 57-67
21. Brandes S.B., and Ruggieri M.R. Muscarinic receptor subtypes in normal, fetal, and gravid rabbit bladder, heart and uterus. Adv Exp Med Biol 385 (1995) 241-249
22. 2 receptors in genito-urinary smooth muscle pathology. Life Sci 64 (1999) 429-436
23. 2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder. Am J Physiol 275 (1998) R1654-R1660
24. 2. Am J Physiol 285 (2003) R701-R708
25. Braverman A.S., and Ruggieri Sr. M.R. Muscarinic receptor transcript and protein density in hypertrophied and atrophied rat urinary bladder. Neurourol Urodyn 25 (2006) 55-61
26. Brodde O.E., and Michel M.C. Adrenergic receptors and their signal transduction mechanisms in hypertension. J Hypertension 10 Suppl. 7 (1992) S133-S145
27. Broten T., Scott A., Siegl P.K.S., Forray C., Lagu B., Nagarathnam D., et al. Alpha-1 adrenoceptor blockade inhibits detrusor instability in rats with bladder outlet obstruction. FASEB J 12 (1998) A445
28. Calvert R.C., Thompson C.S., Khan M.A., Mikhailidis D.P., Morgan R.J., and Burnstock G. Alterations in cholinergic and purinergic signaling in a model of the obstructed bladder. J Urol 166 (2001) 1530-1533
29. Cardozo A.H., Cabrini D.A., Campos M.M., Rae G.A., Huidobro-Toro J.P., and Calixto J.B. Diabetes-induced changes in responsiveness of rat bladder and vas deferens to peptides in vitro: Susceptibility to reversal by insulin. Can J Physiol Pharmacol 80 (2002) 334-340
30. Chacko S., Chang S., Hypolite J., Disanto M., and Wein A. Alteration of contractile and regulatory proteins following partial bladder outlet obstruction. Scand J Urol Nephrol Suppl 215 (2004) 26-36
31. Chai T.C., Gemalmaz H., Andersson K.E., Tuttle J.B., and Steers W.D. Persistently increased voiding frequency despite relief of bladder outlet obstruction. J Urol 161 (1999) 1689-1693
32. Chang S., Hypolite J.A., DiSanto M.E., Changolkar A., Wein A.J., and Chacko S. Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by up-regulation of rho-kinase b and CPI-17. Am J Physiol 290 (2005) F650-F656
33. Chapple C.R., Milner P., Moss H.E., and Burnstock G. Loss of sensory neuropeptides in the obstructed human bladder. Br J Urol 70 (1992) 373-381
34. Chertin B., Rolle U., Cascio S., and Puri P. Alterations in cholinergic and neuropeptide innervation or urinary bladder following partial bladder outlet obstruction. Pediatr Surg Int 19 (2003) 427-431
35. Chetty N., Coupar I.M., Chess-Williams R., and Kerr K.P. Demonstration of 5-HT3 receptor function and expression in the mouse bladder. Naunyn-Schmiedeberg's Arch Pharmacol 375 (2007) 359-368
36. Chiavegato A., Scatena M., Roelofs M., Ferrarese P., Pauletto P., Passerini-Glazel G., et al. Cytoskeletal and cytocontractile protein composition of smooth muscle cells in developing and obstructed rabbit bladder. Exp Cell Res 207 (1993) 310-320
37. Choppin A. Muscarinic receptors in isolated urinary bladder smooth muscle from different mouse strains. Br J Pharmacol 137 (2002) 522-528
38. Chopra B., Barrick S.R., Meyers S., Beckel J.M., Zeidel M.L., Ford A.P.D.W., et al. Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol (London) 562 (2005) 859-871
39. Christ G.J., Hsieh Y., Zhao W., Schenk G., Venkateswarlu K., Wang H.Z., et al. Effects of streptozotocin-induced diabetes on bladder and erectile (dys)function in the same rat in vivo. BJU Int 97 (2006) 1076-1082
40. Clemow D.B., McCarty R., Steers W.D., and Tuttle J.B. Efferent and afferent neuronal hypertrophy associated with micturition pathways in spontaneously hypertensive rats. Neurourol Urodyn 16 (1997) 293-303
41. Cumming J.A., and Chisholm G.D. Changes in detrusor innervation with relief of outflow tract obstruction. Br J Urol 69 (1992) 7-11
42. Dambros M., van Koeveringe G.A., Bast A., and van Kerrebroeck P.E.V. Relaxant effects of estradiol through non-genomic pathways in male and female pig bladder smooth muscle. Pharmacology 72 (2004) 121-127
43. Das A.K., Leggett R.E., Whitbeck C., Eagen G., and Levin R.M. Effect of doxazosin on rat urinary bladder function after partial outlet obstruction. Neurourol Urodyn 21 (2002) 160-166
44. Derweesh I.H., Wheeler M.A., and Weiss R.M. Alterations in G-proteins and β-adrenergic responsive adenylyl cyclase in rat urinary bladder during ageing. J Pharmacol Exp Ther 294 (2000) 969-974
45. DiSanto M.E., Stein R., Chang S., Hypolite J.A., Zheng Y., Zderic S., et al. Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am J Physiol 285 (2003) C1397-C1410
46. Dixon J.S., Gilpin C.J., Gilpin S.A., Gosling J.A., Brading A.F., and Speakman M.J. Sequential morphological changes in the pig detrusor in response to chronic partial urethral obstruction. Br J Urol 64 (1989) 385-390
47. Drake M., Gillespie J., Hedlund P., Harvey I., Lagou M., and Andersson K.E. Muscarinic stimulation of the rat isolated whole bladder: Pathophysiological models of detrusor overactivity. Auton Autacoid Pharmacol 26 (2006) 261-266
48. Elbadawi A., Diokno A.C., and Millard R.J. The aging bladder: Morphology and urodynamics. World J Urol 16 Suppl. 1 (1998) S10-S34
49. Fleichman M., Schneider T., Fetscher C., and Michel M.C. Signal transduction underlying carbachol-induced contraction of rat urinary bladder. II. Protein kinases. J Pharmacol Exp Ther 308 (2004) 54-58
50. Frazier E.P., Braverman A.S., Peters S.L.M., Michel M.C., and Ruggieri Sr. M.R. Does phospholipase C mediate muscarinic receptor-induced rat urinary bladder contraction?. J Pharmacol Exp Ther 322 (2007) 998-1002
51. Frazier E.P., Mathy M.J., Peters S.L.M., and Michel M.C. Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol?. J Pharmacol Exp Ther 313 (2005) 260-267
52. Frazier, E. P., Peters, S. L. M., Braverman, A. S., Ruggieri, M. R., Sr., & Michel, M. C. (in press). Signal transduction underlying contro of urinary bladder smooth muscle tone by muscarinic receptors and β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol. doi:10.1007/s00210-007-0208-0
53. Frazier E.P., Schneider T., and Michel M.C. Effects of gender, age and hypertension on β-adrenergic receptor function in rat urinary bladder. Naunyn-Schmiedeberg's Arch Pharmacol 373 (2006) 300-309
54. Gabella G., and Uvelius B. Structural changes in the rat bladder after acute outlet obstruction. Scand J Urol Nephrol Suppl 201 (1999) 32-37
55. Geloso D.A., and Levin R.M. Effect of partial outlet obstruction on the myogenic response to field stimulation. Gen Pharmacol 31 (1998) 291-295
56. Glynn R.J., Campion E.W., Bouchard G.R., and Silbert J.E. The development of benign prostatic hyperplasia among volunteers in the normative ageing study. Am J Epidemiol 121 (1985) 78-90
57. Goepel M., Gronewald A., Krege S., and Michel M.C. Muscarinic receptor subtypes in porcine detrusor: Comparison with humans and regulation by bladder augmentation. Urol Res 26 (1998) 149-154
58. Goepel M., Hoffmann J., Piro M., Rübben H., and Michel M.C. Prevalence and physician awareness of symptoms of urinary bladder dysfunction. Eur Urol 41 (2002) 234-239
59. Goepel M., Wittmann A., Rübben H., and Michel M.C. Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol Res 25 (1997) 199-206
60. Gosling J.A., Kung L.S., Dixon J.S., Horan P., Whitbeck C., and Levin R.M. Correlation between the structure and function of the rabbit urinary bladder following partial outlet obstruction. J Urol 163 (2000) 1349-1356
61. 1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction. J Urol 172 (2004) 758-762
62. Hampel C., Artibani W., Espuna Pons M., Haab F., Jackson S., Romero J., et al. Understanding the burden of stress urinary incontinence in Europe: A qualitative review of the literature. Eur Urol 46 (2004) 15-27
63. Hampel C., Dolber P.C., Smith M.P., Savic D.L., Thüroff J.W., Thor K.B., et al. Modulation of bladder α1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol 167 (2002) 1513-1521
64. Hawthorn M.H., Chapple C.R., Cock M., and Chess-Williams R. Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 129 (2000) 416-419
65. Hegde S.S. Muscarinic receptors in the bladder: From basic research to therapeutics. Br J Pharmacol 147 (2006) S80-S87
66. Hegde S.S., Mandel D.A., Wilford M.R., Briaud S., Ford A.P.D.W., and Eglen R.M. Evidence for purinergic neurotransmission in the urinary bladder of pithed rats. Eur J Pharmacol 349 (1998) 75-82
67. Hendriks-Balk M.C., Michel M.C., and Alewijnse A.E. Pitfalls in the normalization of real-time polymerase chain reaction data. Bas Res Cardiol 102 (2007) 195-197
68. Holm N.R., Horn T., Smedts F., Nordling J., and de la Rosette J. The detrusor muscle cell in bladder outlet obstruction. Scand J Urol Nephrol 37 (2003) 309-315
69. Howard P.S., Kucich U., Coplen E.E., and He Y. Transforming growth factor-beta1-induced hypertrophy and matrix expression in human bladder smooth muscle cells. Urology 66 (2005) 1349-1353
70. Hu J., Chin C.M., Png J.C., Ng Y.K., and Ling E.A. The effect of chronic bladder outlet obstruction on neuronal nitric oxide synthase expression in the intramural ganglia of the guinea pig bladder. J Urol 172 (2004) 1160-1165
71. Humphreys M.R., and Reinberg Y.E. Contemporary and emerging drug treatments for urinary incontinence in children. Pediatr Drugs 7 (2005) 151-162
72. Irwin D.E., Milsom I., Hunskaar S., Reillly K., Kopp Z., Herschorn S., et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 50 (2006) 1306-1315
73. 1-adrenoceptors. Br J Pharmacol 117 (1996) 962-966
74. Ji P., Karim O.M.A., Boyd C.D., Mostwin J.L., and Ward W.S. Elastin morphology in normal and obstructed guinea-pig bladder. World J Urol 13 (1995) 191-194
75. Khan M.A., Dashwood M.R., Thompson C.S., Mumtaz F.H., Morgan R.J., and Mikhailidis D.P. Time-dependent up-regulation of neuronal 5-hydroxytryptamine binding sites in the detrusor of a rabbit model of partial bladder outlet obstruction. World J Urol 17 (1999) 255-260
76. Kim J.C., Seo S.I., Park Y.H., and Hwang T.K. Changes in detrusor and urinary growth factors according to detrusor function after partial bladder outlet obstruction in the rat. Urology 57 (2001) 371-375
77. Kim K.M., Kang J., and Jung J.Y. Morphometric analysis of the collagen changes induced by subcutaneous injection of intereron-gamma after bladder outlet obstruction in the rat. Neurourol Urodyn 22 (2003) 70-76
78. Kobayashi H., Adachi-Akahane S., and Nagao T. Involvement of BKCa channels in the relaxation of detrusor muscle via β-adrenoceptors. Eur J Pharmacol 404 (2000) 231-238
79. Kojima M., Inui E., Ochiai A., Naya Y., Ukimura O., and Watanabe H. Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: A preliminary report. Urology 47 (1996) 942-947
80. Kolta M.G., Wallace L.J., and Gerald M.C. Age-related changes in sensitivity of rat urinary bladder to autonomic agents. Mech Ageing Dev 27 (1984) 183-188
81. 3?. Naunyn-Schmiedeberg's Arch Pharmacol 367 (2003) 524-531
82. Kortmann B.B.M., Floratos D.L., Kiemeney L.A.L.M., Wijkstra H., and de la Rosette J.J.M.C.H. Urodynamic effects of alpha-adrenoceptor blockers: A review of clinical trials. Urology 62 (2003) 1-9
83. 3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction. J Urol 161 (1999) 1644-1650
84. Lagou M., Gillespie J., Kirkwood T., Harvey I., and Drake M.J. Muscarinic stimulation of the mouse isolated whole bladder: Physiological responses in young and ageing mice. Auton Autacoid Pharmacol 26 (2006) 253-260
85. Lai H.H., Bonne T.B., Thompson T.C., Smith C.P., and Somogyui G.T. Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urology 69 (2007) 407-411
86. Lapitan M.C., and Chye P.L.H. The epidemiology of overactive bladder among females in Asia: A questionnaire study. Int Urogynecol J 12 (2001) 226-231
87. Lasanen L.T., Tammela T.L.J., Kallioinen M., and Waris T. Effect of acute distension on cholinergic innervation of the rat urinary bladder. Urol Res 20 (1992) 59-62
88. Latifpour J., Kondo S., O'Hollaren B., Morita T., and Weiss R.M. Autonomic receptors in urinary tract: Sex and age differences. J Pharmacol Exp Ther 253 (1990) 661-667
89. Lee J.G., Coplen D., Macarak E., Wein A.J., and Levin R.M. Comparative studies on the ontogeny and autonomic responses of the fetal calf bladder at different stages of development: Involvement of nitric oxide on field stimulated relaxation. J Urol 151 (1994) 1096-1101
90. Lefebvre J., Poirier L., Poirier P., Turgeon J., and Lacourciere Y. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension. Br J Clin Pharmacol 63 (2006) 575-582
91. Lemack G.E., Szabo Z., Urban Z., Boyd C.D., Csiszar K., Vaughan Jr. E.D., et al. Altered bladder function in transgenic mice expressing rat elastin. Neurourol Urodyn 18 (1999) 55-68
92. Lemack G.E., Zimmern P.E., Vazquez D., McConnell J.D., and Lin V.K. Altered response to partial bladder outlet obstruction in mice lacking inducible nitric oxide synthase. J Urol 163 (2000) 1981-1987
93. Levin R.M., English M., Barretto M., Dubuc M., O'Connor L., Leggett R., et al. Normal detrusor is more sensitive than hypertrophied detrusor to in vitro ischemia followed by re-oxygenation. Neurourol Urodyn 19 (2000) 701-712
94. Levin R.M., Haugaard N., O'Connor O., Buttyan R., Das A., Dixon J.S., et al. Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: A direct comparison. Neurourol Urodyn 19 (2000) 609-629
95. Levin R.M., Longhurst P.A., Whitbeck C., and Korstanje C. The effect of tamsulosin on the response of the rabbit bladder to partial bladder outlet obstruction. Neurourol Urodyn 25 (2006) 89-94
96. Levin R.M., Malkowicz S.B., Wein A.J., Atta M.A., and Elbadawi A. Recovery from short-term obstruction of the rabbit urinary bladder. J Urol 134 (1985) 388-390
97. Levin R.M., Saito M., Wein A.J., Packard D., Cohen A., and Haugaard N. Effect of partial outlet obstruction on choline acetyltransferase activity in the rat and rabbit. Neurourol Urodyn 12 (1993) 255-261
98. Li G., Li K., Li Z., and Wang P. Age-dependent changes in β-adrenoceptor function in human detrusor and possible mechanisms. Chin Med J 116 (2003) 1511-1514
99. Lin A.T., Yang C.H., Chen C.J., Chen M.T., Chiang H., and Chang L.S. Correlation of contractile function and passive properties of rabbit urinary bladder subjected to outlet obstruction - An in vitro whole bladder study. J Urol 148 (1992) 944-948
100. Lluel P., Barras M., and Palea S. Cholinergic and purinergic contribution to the micturition reflex in conscious rats with long-term bladder outlet obstruction. Neurourol Urodyn 21 (2002) 142-153
101. Lluel P., Deplanne V., Heudes D., Bruneval P., and Palea S. Age-related changes in urethrovesical coordination in male rats: Relationship with bladder instability?. Am J Physiol 284 (2003) R1287-R1295
102. Lluel P., Duquenne C., and Martin D. Experimental bladder instability following bladder outlet obstruction in the female rat. J Urol 160 (1998) 2253-2257
103. Lluel P., Palea S., Barras M., Grandadam F., Heudes D., Bruneval P., et al. Functional and morphological modifications of the urinary bladder in aging female rats. Am J Physiol 278 (2000) R964-R972
104. Lluel P., Salea S., Rbiere P., Barras M., Teillet L., and Corman B. Increased adrenergic contractility and decreased mRNA expression of NOS III in aging rat urinary bladders. Fundam Clin Pharmacol 17 (2003) 633-641
105. Longhurst P.A. Developmental aspects of bladder function. Scand J Urol Nephrol Suppl 215 (2004) 11-19
106. Longhurst P.A., and Levendusky M. Influence of gender and the oestrous cycle on in vitro contractile responses of the rat urinary bladder to cholinergic stimulation. Br J Pharmacol 131 (2000) 177-184
107. Longhurst P.A., Levendusky M.C., and Bezuijen M.W.F. Diabetes mellitus increases the rate of development of decompensation in rats with outlet obstruction. J Urol 171 (2004) 933-937
108. Mansfield K.J., Liu L., Mitchelson F.J., Moore K.H., Millard R.J., and Burcher E. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: Changes in ageing. Br J Pharmacol 144 (2005) 1089-1099
109. Matsubara S., Okada H., Shirakawa T., Gotoh A., Kuno T., and Kamidono S. Estrogen levels influence beta-3-adrenoceptor-mediated relaxation of the female rat detrusor muscle. Urology 59 (2002) 621-625
110. Matsumoto S., Hanai T., Ohnishi N., Yamamoto K., and Kurita T. Bladder smooth muscle cell phenotypic changes and implication of expression of contractile proteins (especially caldesmon) in rats after partial outlet obstruction. Int J Urol 10 (2003) 339-345
111. Michel M.C., de la Rosette J.J.M.C.H., Piro M., and Goepel M. Does concomitant stress incontinence alter the efficacy of tolterodine in patients with overactive bladder?. J Urol 172 (2004) 601-604
112. Michel M.C., Heemann U., Schumacher H., Mehlburger L., and Goepel M. Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol 172 (2004) 1390-1393
113. Michel M.C., and Hegde S.S. Treatment of the overactive bladder syndrome with muscarinic receptor antagonists - A matter of metabolites?. Naunyn-Schmiedeberg's Arch Pharmacol 374 (2006) 79-85
114. Michel M.C., Mehlburger L., Schumacher H., Bressel H.U., and Goepel M. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 163 (2000) 1725-1729
115. Michel M.C., Oelke M., and Peters S.L.M. The neuro-urological connection. Eur Urol Suppl 4 (2005) 18-28
116. Michel M.C., Schäfers R.F., and Goepel M. α-Blockers and lower urinary tract function: More than smooth muscle relaxation?. BJU Int 86 Suppl. 2 (2000) 23-30
117. Michel M.C., Schneider T., Krege S., and Goepel M. Do gender or age affect the efficacy and safety of tolterodine?. J Urol 168 (2002) 1027-1031
118. 2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147 (2006) S88-S119
119. Milsom I., Abrams P., Cardozo L., Roberts R.G., Thüroff J.W., and Wein A.J. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87 (2001) 760-766
120. Moffatt J.D. Proteinase-activated receptors in the lower urinary tract. Naunyn-Schmiedeberg's Arch Pharmacol 374 (2007) 1-9
121. Moore C.K., Levendusky M., and Longhurst P.A. Relationship of mass of obstructed rat bladders and responsiveness to adrenergic stimulation. J Urol 168 (2002) 1621-1625
122. Morita T., Masuda H., Tosaka A., Ishizaka K., Tsuhii T., and Kondo S. Sex differences in function and distribution of β-adrenoceptors in rabbit urinary bladder. J Urol 159 (1998) 555-558
123. Mueller E., Latini J., Lux M., Stablein U., Brubaker L., Kreder K., et al. Gender differences in 24-hour urinary diaries of asymptomatic North American adults. J Urol 173 (2005) 490-492
124. Niclauß N., Michel-Reher M.B., Alewijnse A.E., and Michel M.C. Comparison of three radioligands for the labelling of human β-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 374 (2006) 79-85
125. Nishimoto T., Latifpour J., Wheeler M.A., Yoshida M., and Weiss R.M. Age-dependent alterations in b-adrenergic responsiveness of rat detrusor smooth muscle. J Urol 153 (1995) 1701-1705
126. Nomiya M., and Yamaguchi O. A quantitative analysis of mRNA expression of α1 and β-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170 (2003) 649-653
127. Norby B., Nordling J., and Mortensen S. Lower urinary tract symptoms in the Danish population: A population-based study of symptom prevalence, health-care seeking behavior and prevalence of treatment in elderly males and females. Eur Urol 47 (2005) 817-823
128. Oelke M., Höfner K., Wiese B., Grünewald V., and Jonas U. Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World J Urol 19 (2002) 443-452
129. Ordway G.A., Esbenshade T.A., Kolta M.G., Gerald M.C., and Wallace L.J. Effect of age on cholinergic muscarinic responsiveness and receptors in the rat urinary bladder. J Urol 136 (1986) 492-496
130. Ordway G.A., Kolta M.G., Gerald M.C., and Wallace L.J. Age-related change in α-adrenergic responsiveness of the urinary bladder of the rat is regionally specific. Neuropharmacol 25 (1986) 1335-1340
131. Öztürk B., Centinkaya M., Gür S., Ugurlu Ö., Öztekin V., and Aki F.T. The early effects of partial outflow obstruction on contractile properties of diabetic and non-diabetic rat bladder. Urol Res 30 (2002) 178-184
132. Pagala M.K., Tetsoti L., Nagpal D., and Wise G.J. Aging effects on contractility of longitudinal and circular detrusor and trigone of rat bladder. J Urol 166 (2001) 721-727
133. Pandita R.K., Fujiwara M., Alm P., and Andersson K.E. Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction. J Urol 165 (2000) 1385-1389
134. Persson K., Pandita R.K., Spitsbergen J.M., Steers W.D., Tuttle J.B., and Andersson K.E. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am J Physiol 275 (1998) R1366-R1373
135. Peters S.L.M., Schmidt M., and Michel M.C. Rho kinase: A target for treating urinary bladder dysfunction?. Trends Pharmacol Sci 27 (2006) 492-497
136. Peters T.J., Donovan J.L., Kay H.E., Abrams P., de la Rosette J.J.M.C.H., Porru D., et al. The International Continence Society "Benign Prostatic Hyperplasia" study: The bothersomeness of urinary symptoms. J Urol 157 (1997) 885-889
137. + channels by β-adrenoceptors in guinea pig urinary bladder smooth muscle. Am J Physiol Cell Physiol 288 (2005) C1255-C1263
138. Pinna C., Caratozzolo O., and Puglisi L. A possible role of urinary bladder epithelium in bradykinin-induced contraction in diabetic rats. Eur J Pharmacol 214 (1992) 143-148
139. Rajasekaran M., Wilkes N., Kuntz S., and Albo M.E. Rho-kinase inhibition suppresses bladder hyperreactivity in spontaneously hypertensive rats. Neurourol Urodyn 24 (2005) 295-300
140. Rapp D.E., Lyon M.B., Bales G.T., and Cook S.P. A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur Urol 48 (2005) 303-308
141. Ruggieri Sr. M.R., and Braverman A.S. Regulation of bladder muscarinic receptor subtypes by experimental pathologies. Auton Autacoid Pharmacol 26 (2006) 311-325
142. Saito M., Longhurst P.A., Tammela T.L.J., Wein A.J., and Levin R.M. Effects of partial outlet obstruction of the rat urinary bladder on micturition characteristics, DNA synthesis and the contractile response to field stimulation and pharmacological agents. J Urol 150 (1993) 1045-1051
143. Saito M., Wein A.J., and Levin R.M. Effect of partial outlet obstruction on contractility: Comparison between severe and mild obstruction. Neurourol Urodyn 12 (1993) 573-583
144. Santarosa R., Colombel M.C., Kaplan S., Monson F., Levin R.M., and Buttyan R. Hyperplasia and apoptosis. Opposing cellular processes that regulate the response of the rabbit bladder to transient outlet obstruction. Lab Invest 70 (1994) 503-510
145. Schmidt M., Sand C., Jakobs K.H., Michel M.C., and Oude Weernink P.A. Epac and the cardiovascular system. Curr Opin Pharmacol 7 (2007) 193-200
146. Schneider T., Fetscher C., Krege S., and Michel M.C. Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Pharmacol Exp Ther 309 (2004) 1148-1153
147. Schneider T., Hein P., Bai J., and Michel M.C. A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction?. J Urol 173 (2005) 2178-2181
148. 2+ sources. J Pharmacol Exp Ther 308 (2004) 47-53
149. Schneider T., Hein P., Michel-Reher M., and Michel M.C. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder. Naunyn-Schmiedeberg's Arch Pharmacol 372 (2005) 71-78
150. Schröder A., Chichester P., Kogan B.A., Longhurst P.A., Lieb J., Das A.K., et al. Effect of chronic bladder outlet obstruction on blood flow of the rabbit bladder. J Urol 165 (2001) 640-646
151. Schulte-Baukloh H., Mürtz G., Henne T., Michael T., Miller K., and Knispel H.H. Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: A prospective analysis. BJU Int 97 (2006) 355-358
152. Seaman E.K., Jacobs B.Z., Blaivas J.G., and Kaplan S.A. Persistence or recurrence of symptoms after transurethral resection of the prostate: A urodynamic assessment. J Urol 152 (1994) 935-937
153. Sidney S., Quesenberry Jr. S., Sadler M.C., Lydick E.G., Guess H.A., and Cattolica E.V. Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology 38 Suppl. 1 (1991) 13-19
154. Somlyo A.P., and Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature 372 (1994) 231-236
155. Speakman M.J., Brading A.F., Gilpin C.J., Dixon J.S., Gilpin S.A., and Gosling J.A. Bladder outflow obstruction - A cause of denervation supersensitivity. J Urol 138 (1987) 1461-1466
156. Spitsbergen J.M., Clemow D.B., McCarty R., Steers W.D., and Tuttle J.B. Neurally mediated hyperactive voiding in spontaneously hypertensive rats. Brain Res 790 (1998) 151-159
157. Steers W.D., Ciambotti J., Erdman S., and De Groat W.C. Morphological plasticity in efferent pathways to the urinary bladder of the rat following urethral obstruction. J Neurosci 10 (1990) 1943-1951
158. Steers W.D., Clemow D.B., Persson K., Sherer T.B., Andersson K.E., and Tuttle J.B. The spontaneously hypertensive rat: Insight into the pathogenesis of irritative symptoms in benign prostatic hyperplasia and young anxious males. Exp Physiol 84 (1999) 137-147
159. Stevens L.A., Sellers D.J., McKay N.G., Chapple C.R., and Chess-Williams R. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder. Auton Autacoid Pharmacol 26 (2006) 303-309
160. Stewart W.F., van Rooyen J.B., Cundiff G.W., Abrams P., Herzog A.R., Corey R., et al. Prevalence and burden of overactive bladder in the United States. World J Urol 20 (2003) 327-336
161. Sutherland R.S., Baskin L.S., Kogan B.A., and Cunha G. Neuroanatomical changes in the rat bladder after bladder outlet obstruction. Br J Urol 82 (1998) 865-901
162. Szallasi A. Small molecule vanilloid TRPV1 receptor ligands approaching drug status: Can they live up to the expectations?. Naunyn-Schmiedeberg's Arch Pharmacol 373 (2006) 273-286
163. 1-adrenoceptor responsiveness in female beagle dogs. J Urol 156 (1996) 1485-1488
164. Taylor J., Harrison S.C.W., Assassa R.P., and McGrother C.W. The pattern and progression of lower urinary tract symptoms after transurethral prostatectomy compared with those seen in the general population. Eur Urol 51 (2007) 1023-1030
165. Tong Y.C., Hung Y.C., Lin S.N., and Cheng J.T. The norepinephrine tissue concentration and neuropeptide Y immunoreactivity in genitourinary organs of the spontaneously hypertensive rat. J Auton Nerv System 56 (1996) 215-218
166. Tugay M., Yildiz F., Utkan T., Gacar N., Ulak G., and Erden F. Age-related smooth muscle reactivity changes in the rat bladder: An in vitro study. Pharmacol Res 48 (2003) 329-334
167. Turner W.H., and Brading A.F. Smooth muscle of the bladder in the normal and the diseased state: Pathophysiology, diagnosis and treatment. Pharmacol Ther 75 (1999) 77-110
168. Uchida H., Shishido K., Nomiya M., and Yamaguchi O. Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via β-adrenoceptors. Eur J Pharmacol 518 (2005) 195-202
169. Ukai M., Yuyama H., Noguchi Y., Someya A., Okutsu H., Watanabe M., et al. Participation of endogenous endothelin and ETA receptor in premicturition contractions in rats with bladder outlet obstruction. Naunyn-Schmiedeberg's Arch Pharmacol 373 (2006) 197-203
170. Usta C., Kukul E., and Yalcinkaya M. Doxazosin effects on cholinergic and adrenergic responses in rat isolated detrusor smooth muscle preparations from obstructed bladder. J Pharmacol Sci 95 (2004) 205-310
171. Uvelius B., Persson L., and Mattiasson A. Smooth muscle cell hypertrophy and hyperplasia in the rat detrusor after short-time infravesical outflow obstruction. J Urol 131 (1984) 173-176
172. 3-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 374 (2007) 385-398
173. Wegener J.W., Schulla V., Lee T.S., Koller A., Feil S., Feil R., et al. An essential role of CaV1.2 L-type calcium channel for urinary bladder function. FASEB J 18 (2004) 1159-1161
174. Wibberley A., Chen Z., Hu E., Hieble J.P., and Westfall T.D. Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle. Br J Pharmacol 138 (2003) 757-766
175. Woods M., Carson N., Norton N.W., Sheldon J.H., and Argentieri T.M. Efficacy of the β3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat. J Urol 166 (2001) 1142-1147
176. Wuest M., Braeter M., Schoeberl C., and Ravens U. Juvenile pig detrusor: Effects of propiverine and three of its metabolites. Eur J Pharmacol 524 (2005) 145-148
177. Wuest, M., Eichhorn, B., Braeter, M., Strugala, G., Michel, M.C., & Ravens, U. (in press). Muscarinic receptor expression and receptor-mediated detrusor contraction: comparison of juvenile and adult porcine tissue. Pflügers Arch. doi:10.1007/s00424-007-0407-z
178. Wuest M., Kaden S., Hakenberg O.W., Wirth M.P., and Ravens U. Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium. Naunyn-Schmiedeberg's Arch Pharmacol 372 (2005) 203-212
179. Wuest M., Morgenstern K., Graf E.M., Braeter M., Hakenberg O.W., Wirth M.P., et al. Cholinergic and purinergic responses in isolated human detrusor in relation to age. J Urol 173 (2005) 2182-2189
180. Wuest M., Weiss A., Waelbrock M., Braeter M., Kelly L.U., Hakenberg O.W., et al. Propiverine and metabolites: Differences in binding to muscarinic receptors and in functional models of detrusor contraction. Naunyn-Schmiedeberg's Arch Pharmacol 374 (2006) 87-97
181. 3-Adrenoceptors in urinary bladder. Neurourol Urodyn 26 (2007) 752-756
182. Yono M., Pouresmail M., Takahashi W., Flanagan J.F., Weiss R.M., and Latifpour J. Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes. Naunyn-Schmiedeberg's Arch Pharmacol 372 (2005) 251-255
183. Yoshida M., Homma Y., Inadome A., Yono M., Seshita H., Miyamoto Y., et al. Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles. Exp Gerontol 36 (2001) 99-109
184. Yoshimura Y., Schmidt F., and Constantinou C.E. Gender specificity of tolterodine on micturition and the diurnal variation of urine production of the conscious rat. BJU Int 87 (2000) 879-885
185. Yu H.J., Wein A.J., and Levin R.M. Contractile responses and calcium mobilization induced by muscarinic agonists in the rat urinary bladder: Effects of age. Gen Pharmacol 28 (1997) 623-628
186. Zderic S.A., Duckett J.W., Wein A.J., Snyder H.M.I., and Levin R.M. Developmental factors in the contractile response of the rabbit bladder to both autonomic and non-autonomic agents. Pharmacology 41 (1990) 119-123
187. Zderic S., Sillen U., Liu G.H., Snyder H.M.I., Duckett J.W., Gong C., et al. Developmental aspects of excitation contraction coupling of rabbit bladder smooth muscle. J Urol 152 (1994) 679-681
188. Zhang E.Y., Stein R., Chang S., Zheng Y., Zderic S.A., Wein A.J., et al. Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am J Pathol 164 (2004) 601-612